| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVITA Medical, Inc. | Chief Financial Officer | Common Stock | 46,450 | $578,303 | $12.45 | 01 Jul 2022 | Direct |
| Cytek Biosciences, Inc. | Director | Restricted Stock Units | 13,819 | $104,262 | $5.31 | 18 Nov 2025 | Direct |
| Cytek Biosciences, Inc. | Director | Common Stock | 12,359 | $51,289 | $4.15 | 18 Nov 2025 | Direct |
| Cytek Biosciences, Inc. | Director | Director Stock Option (right to buy) | 23,809 | 18 Jun 2025 | Direct | ||
| AVITA Medical, Inc. | Chief Financial Officer | Stock Options (Right to Buy) | 20,650 | 01 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTKB | Cytek Biosciences, Inc. | 18 Nov 2025 | 2 | $0 | 4 | Director | 20 Nov 2025, 18:53 |
| CTKB | Cytek Biosciences, Inc. | 18 Aug 2025 | 2 | $0 | 4 | Director | 20 Aug 2025, 17:43 |
| CTKB | Cytek Biosciences, Inc. | 18 Jun 2025 | 2 | $0 | 4 | Director | 20 Jun 2025, 16:18 |
| CTKB | Cytek Biosciences, Inc. | 19 May 2025 | 2 | $0 | 4 | Director | 21 May 2025, 17:48 |
| CTKB | Cytek Biosciences, Inc. | 10 Mar 2025 | 2 | $0 | 4 | Director | 12 Mar 2025, 17:47 |
| CTKB | Cytek Biosciences, Inc. | 18 Nov 2024 | 2 | $0 | 4 | Director | 20 Nov 2024, 18:16 |
| CTKB | Cytek Biosciences, Inc. | 19 Aug 2024 | 2 | $0 | 4 | Director | 21 Aug 2024, 18:28 |
| CTKB | Cytek Biosciences, Inc. | 05 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 19:09 |
| CTKB | Cytek Biosciences, Inc. | 05 Jun 2024 | 0 | $0 | 3 | Director | 07 Jun 2024, 19:05 |
| RCEL | AVITA Medical, Inc. | 01 Jul 2022 | 2 | $0 | 4 | Chief Financial Officer | 06 Jul 2022, 18:57 |
| RCEL | AVITA Medical, Inc. | 06 Jul 2021 | 2 | $0 | 4 | Chief Financial Officer | 07 Sep 2021, 16:05 |
| RCEL | AVITA Medical, Inc. | 11 May 2021 | 1 | $0 | 4 | Chief Financial Officer | 11 May 2021, 21:52 |